Latest Insights on Executive Summary Taxane-Based Oncology Drug Class Market Share and Size CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period The study and analysis conducted in this industry...